Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05277129

The Immune Response to Stroke

Status
Recruiting
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
University of Oslo · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Some patients develop cognitive decline after a stroke, but we don't always understand the mechanisms. It has been proposed that a proportion of the patients develop an autoimmune immune response, and that this could potentially explain the cognitive decline in some of the patients. The current study aims to investigate this hypothesis in a subgroup of patients with stroke.

Conditions

Interventions

TypeNameDescription
OTHERAnalysis of post-stroke immune responsesAnalysis of immune responses in peripheral blood

Timeline

Start date
2021-06-24
Primary completion
2025-12-31
Completion
2029-06-06
First posted
2022-03-14
Last updated
2022-03-14

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT05277129. Inclusion in this directory is not an endorsement.

The Immune Response to Stroke (NCT05277129) · Clinical Trials Directory